Inhibiting CCL7 for diabetic vascular disease
Inhibiting the chemokine CCL7 could help treat diabetic vascular disease by promoting AKT signaling and preventing ERK signaling in endothelial cells, which increases angiogenesis while decreasing inflammation.
CCL7 levels were higher in the plasma and endothelial progenitor cells of blood from Type II diabetic patients than from healthy individuals. ...
BCIQ Company Profiles